Founded Year

2015

Stage

Unattributed - II | Alive

Total Raised

$16.642B

Last Raised

$1.27B | 1 yr ago

Revenue

$0000 

About JUUL Labs

JUUL Labs is a company focused on alternative nicotine delivery systems within the tobacco industry. The company's main offerings include electronic cigarettes that deliver a nicotine-containing e-liquid formulation. JUUL Labs also implements measures to prevent underage usage of its products. It was formerly known as PAX and changed its name to JUUL Labs in June 2017. The company was founded in 2015 and is based in San Francisco, California.

Headquarters Location

560 20th Street

San Francisco, California, 94107,

United States

415-829-2336

Loading...

Loading...

Expert Collections containing JUUL Labs

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

JUUL Labs is included in 2 Expert Collections, including Unicorns- Billion Dollar Startups.

U

Unicorns- Billion Dollar Startups

1,270 items

T

Tech IPO Pipeline

286 items

JUUL Labs Patents

JUUL Labs has filed 307 patents.

The 3 most popular patent topics include:

  • dosage forms
  • drug delivery devices
  • routes of administration
patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/17/2019

3/25/2025

Fluid dynamics, Dosage forms, Drug delivery devices, Control flow, Electronic cigarettes

Grant

Application Date

10/17/2019

Grant Date

3/25/2025

Title

Related Topics

Fluid dynamics, Dosage forms, Drug delivery devices, Control flow, Electronic cigarettes

Status

Grant

Latest JUUL Labs News

UPC revocation actions: What is a reasonable number of auxiliary requests?

Mar 13, 2025

To embed, copy and paste the code into your website or blog: <iframe frameborder="1" height="620" scrolling="auto" src="//www.jdsupra.com/post/contentViewerEmbed.aspx?fid=1f756328-75a5-4dc2-8db6-6900399e2e3a" style="border: 2px solid #ccc; overflow-x:hidden !important; overflow:hidden;" width="100%"></iframe> Two recent UPC decisions have provided some guidance on the admissibility and reasonableness of auxiliary requests in revocation actions. The court will look at the specific circumstances and complexity of the revocation claim, in particularly the number of invalidity grounds raised, the importance of the patents in issue, and the interrelationship with other proceedings. 10x Genomics, Inc. and Harvard College v Nanostring Technologies Inc. (UPC_CFI-298/2023), Munich Local Division (13 January 2025) Nanostring had brought proceedings against 10x Genomics and Harvard to revoke a patent relating to detection reagents, compositions and methods for detecting, and quantifying analytes in a sample. In its defence, Harvard had filed 55 auxiliary requests to amend the patent and there was a question whether this was a reasonable number in the circumstances of the case. The parties had agreed that the UPC proceedings should be stayed pending a decision of the Opposition Division in parallel EPO proceedings. Judge rapporteur The UPC proceedings should be stayed until the decision of the EPO Opposition Division; The number of auxiliary requests should be limited to a single-digit number (i.e. less than 10); and Given the stay, the limited number of auxiliary requests needed to be submitted within 20 days of the Opposition Division’s decision (when the stay would be lifted). Appeal to full panel Harvard asked for a panel review of the decision to reduce the number of allowable auxiliary requests. The full panel reasoned that it would be absurd to stay UPC proceedings because of parallel EPO proceedings but then refuse to introduce in the UPC proceedings an auxiliary request that had been the subject of the EPO proceedings. Accordingly, Harvard should be allowed to adjust its auxiliary requests after the decision of the Opposition Division, to take account of what happened before the EPO. The judge rapporteur was therefore right to give Harvard the opportunity to adjust its auxiliary requests within 20 days of the decision of the Opposition Division. However, the judge rapporteur was wrong to reduce the number of auxiliary requests to a one-digit number. As had been stated in Merril v Edwards Lifesciences (UPC_CFI_255/2023, ACT_551308/2023), the question of whether the number of auxiliary requests is reasonable needs to be assessed in light of the scope of the particular counterclaim for revocation. Whilst 55 auxiliary requests is a high number, potentially hindering the efficiency of the UPC proceedings and the goal of delivering expeditious decisions, it wasn’t unreasonable, considering the extreme complexity of the case (in particular, the 42 grounds of invalidity raised), the importance of the patent at issue and the interrelationship with other proceedings, both judicial and administrative. Furthermore, pursuant to the principle of fairness set out in Art 42 UPCA, the patentee, as a defendant to a revocation counterclaim, should have the right to defend against all attacks brought in the counterclaim. Accordingly, the relevant order was revised to allow the patentee to submit its auxiliary requests within 20 days of the Opposition Division’s decision. The court couldn’t assess whether the number of auxiliary requests would ultimately be determined to be reasonable so that question would remain unanswered until a later stage. In any event, a high number of auxiliary attacks would not necessarily be unreasonable in light of the numerous validity attacks in the counterclaim. The decision of the Opposition Division would also be taken into account. Key Takeaways This appears to be a sensible decision at the particular stage of the proceedings, which emphasises the need to consider the specific circumstances of each case at the appropriate stage of the proceedings. It also highlights the importance of allowing patentees to adjust their auxiliary requests based on developments in related EPO proceedings. When deciding what is a reasonable number of auxiliary requests, the court should look at: The complexity of the case, in particular the number of invalidity grounds raised; The importance of the patents in issue; and The interrelationship with other proceedings. This decision also implies that there is no fixed numerical figure for the reasonable number of auxiliary requests, even if, in particularly complex cases, the number is large. It all depends on the circumstances of the case. Indeed the Paris Central Division in Merril v Edwards Lifesciences had allowed the number of amendments originally filed, even there were 84 auxiliary requests, because of the extreme complexity of the case, the grounds of invalidity raised, the importance of the patent at issue and the interrelationship with other proceedings concerning related patents of the same family. NJOY Netherlands B.V. v. Juul Labs International, Inc. (UPC_CFI_316/2023), Paris Central Division (17 January 2025) This decision was given by the Paris Central Division four days later and it confirms the principle that large numbers of auxiliary requests need to be justified in the circumstances of the case. The proceedings concerned a revocation action brought by NJOY against Juul Lab’s European Patent EP 3 430 921 B1 for vaporizer technology on grounds of added matter, lack of novelty, and lack of inventive step. Juul Labs, in its defence, filed an application to amend the patent, which initially included 57 auxiliary requests. The auxiliary requests filed by the defendant were not examined by the Court, as the revocation action was dismissed, and the auxiliary requests were conditional on the revocation of the patent as granted. However, the Court made some procedural statements regarding the admissibility of the auxiliary requests, which are relevant for the analysis of the case law. Notably the Court highlighted that, in June 2024, an order gave Juul Lab the option to narrow down the auxiliary requests already on file and in October 2024 Juul Labs identified 12 auxiliary requests to be pursued at the oral hearing. The court considered to this to be expedient for an efficient procedure. The court rejected a further request to review 65 auxiliary requests, so far as they went further than the 12, because this was an unreasonable number in the circumstances of the case. The Court considered that the proposed 12 conditional amendments that formed the 12 auxiliary requests were the upper limit for what could be considered reasonable in this particular case. This decision also illustrates the issue of the admissibility of supplementary auxiliary requests. In this case, Juul Labs filed a new auxiliary request with the UPC shortly after a decision of the EPO raised doubts about the clarity of the claims. However, the UPC considered this new auxiliary request as late filed, since the clarity objection had been raised by NJOY, and Juul Labs should have taken it seriously earlier. This is consistent with the UPC’s case law, which emphasises that parties are under an obligation to set out their full case as early as possible under the front-loaded system of the UPC proceedings, according to Preamble RoP 7 (UPC_CFI_263/2023, CD Paris, Bitzer v Carrier Corporation; UPC_CFI_252/2023, CD Munich, Nanostring v Harvard). The UPC also takes into account the arguments already submitted by the claimant for revocation when assessing the admissibility of a new amendment (UPC_CFI_219/2023, LD Mannheim, Panasonic v Xiaomi; UPC_CFI_210/2023, LD Mannheim, Panasonic v Orope). Therefore, it is advisable for patent holders to consider all the invalidity grounds as serious and to prepare auxiliary requests accordingly. Conclusion The admissibility of auxiliary requests is subject to both formal and substantive criteria, which are governed by the RoP and the European Patent Convention (EPC). The formal criteria set out in the RoP include the timely filing of the request to amend the patent, the provision of an explanatory statement, and the clarity, conciseness and support of the amended claims. The substantive criteria include compliance with the provisions of the EPC, such as the prohibition on adding subject-matter and extending protection, and the prima facie admissibility of the amended claims, which means that they must address the grounds for revocation raised by the claimant. In addition, the Court has the discretion to assess the admissibility of auxiliary requests, taking into account the principles of procedural efficiency, fairness and proportionality, as well as the specific circumstances of the case. The Court may also invite the patent holder to reduce the number of auxiliary requests, in order to facilitate the Court’s examination of the admissibility of the amended claims. 1. ORD_51811/2024; ORD_51812/2024; ORD_51813/2024

JUUL Labs Frequently Asked Questions (FAQ)

  • When was JUUL Labs founded?

    JUUL Labs was founded in 2015.

  • Where is JUUL Labs's headquarters?

    JUUL Labs's headquarters is located at 560 20th Street, San Francisco.

  • What is JUUL Labs's latest funding round?

    JUUL Labs's latest funding round is Unattributed - II.

  • How much did JUUL Labs raise?

    JUUL Labs raised a total of $16.642B.

  • Who are the investors of JUUL Labs?

    Investors of JUUL Labs include Altria Group, Tiger Global Management, Capital Group Private Markets, PAX, IPD Capital and 9 more.

  • Who are JUUL Labs's competitors?

    Competitors of JUUL Labs include NJOY and 8 more.

Loading...

Compare JUUL Labs to Competitors

X
Xhale O2

Xhale O2 is a manufacturer of e-cigarettes. The company manufactures and wholesales electronic cigarettes, e-hookah, and vape pipes. The company is based in San Jose, California.

A
Artisan Vapor Franchise

Artisan Vapor Franchise specializes in electronic cigarettes and related supplies within the vaping industry. The company offers a variety of e-cigarettes, e-liquids, CBD products, and vaping accessories designed to provide an alternative to traditional tobacco smoking. Artisan Vapor Franchise primarily caters to the vaping community and individuals looking for smoking alternatives. It was founded in 2012 and is based in Plano, Texas.

V
VOOPOO

VOOPOO is a prominent vape brand known for its advanced technology in the vaping industry. The company offers a range of vaping devices and accessories that cater to both beginners and experienced vapers, featuring rapid firing and precise temperature control. VOOPOO's products are designed with the innovative GENE chip, enhancing the vaping experience with power and temperature control capabilities. It was founded in 2017 and is based in Shenzhen, Guangdong.

G
Geekvape

Geekvape is a leading supplier of vape products and solutions in the e-cigarette industry. The company offers a range of vaping devices and accessories designed to provide a healthier vaping experience, including starter kits, durable mods, and leakproof tanks. Geekvape primarily serves the vaping community and aims to innovate for a better user experience. It is based in Shenzhen, Guangdong.

I
Innokin Technology

Innokin Technology specializes in the design and manufacturing of innovative vaping devices and electronic cigarettes within the vaping industry. The company offers a range of products including pod systems, vape kits, and tanks that cater to both beginners and experienced users, featuring technologies like mesh coils and water-based vaping. Innokin's products are designed to provide a smoke-free alternative to traditional cigarettes, with a focus on quality and reliability. It was founded in 2011 and is based in Shenzhen, Guangdong.

F
Fedrs

Fedrs is a company that produces nicotine pouches within the nicotine delivery industry. Their offerings include flavored nicotine pouches available in different strengths to cater to user preferences. These products provide an alternative for nicotine consumption without the need for traditional smoking or chewing tobacco. It is based in Warsaw, Poland.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.